Brought to you by 
Affymetrix licenses Gemini's COLIA1 for GeneChip arrays
02 Aug 1999
Executive Summary
UK bioinformatics company Gemini Holdings PLC has licensed exclusive rights to its patented collagen Type 1 (COLIA1) polymorphism to Affymetrix Inc. Affymetrix will use COLIA1 on its GeneChip arrays for osteoporosis research and diagnostic applications.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Drug Discovery Tools
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Affymetrix licenses Gemini's COLIA1 for GeneChip arrays
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice